United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 4, 2026

On Jun 4, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$547.07 for US$4.54M under a trading plan, leaving 45,172 shares. Filed Jun 4, 2026 (Form 4).

Sold
8,300 shares
Price
US$547.07 average (US$539.76 to US$549.49)
Value
US$4.54M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockOption exercise8,300US$146.0353,472Direct
Jun 4, 2026Common StockSale200US$539.7653,272Direct
Jun 4, 2026Common StockSale840US$543.8952,432Direct
Jun 4, 2026Common StockSale374US$545.2752,058Direct
Jun 4, 2026Common StockSale2,627US$546.4249,431Direct
Jun 4, 2026Common StockSale935US$547.1148,496Direct
Jun 4, 2026Common StockSale1,481US$548.4347,015Direct
Jun 4, 2026Common StockSale593US$549.4946,422Direct
Jun 4, 2026Common StockSale1,250US$549.4745,172Direct

Source

View original at SEC

Related